Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency — Stella

Home/Alpha 1-Antitrypsin/

View on ClinicalTrials.gov

Recruiting

Back to Alpha 1-Antitrypsin trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

University of Alabama at Birmingham, Birmingham, Alabama

Key details

Phase

Post-approval study

Sponsor

University of Alabama at Birmingham

Collaborators

Alpha-1 Foundation

Enrollment target

~30 participants

Started

September 2025

Primary completion

March 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

19 Years and older

Last updated November 2025